New drugs offer hope for Alzheimer’s patients - Karmavision

www.karmavision.tv When you ask Howard Ulene to sum up what it’s like to live with Alzheimer’s disease there’s no hesitation. Howard Ulene, Alzheimer’s disease patient, drug trial participant: “In one word, forgetfulness and in many words forgetfulness.” Once a savvy businessman, Howard Ulene is now using his entrepreneurial spirit to battle the disease. Howard Ulene, Alzheimer’s disease patient, drug trial participant: “What you have to do is get over the fear and be very maudlin and poignant about it and then say I’m going to beat you SOB because I simply won’t except this limited life.” About two years ago Howard joined a clinical drug trial for Alzheimer’s disease. The drug he received, now known as Flurizan, has just entered phase three of the drug trial. Sam Gandy, MD, Alzheimer’s Association: “Making it to phase three is really unprecedented and these are medicines the likes of which we’ve never seen before. I think the chances of hitting something successful in the next five years are very good.” There are nine new Alzheimer’s treatments in phase three trials-the final step before FDA approval. All offering hope to either slow down or prevent the onset of Alzheimer’s. Sam Gandy, MD, Alzheimer’s Association: “There are several steps leading from the beginning of the disease to what we see clinically, and what we hope to do is aim a different bullet, aim a different medicine at each of those steps.” For Howard, the improvement from taking Flurizan has been …

Related posts:

1. Drugs and Treatments Used to Combat Alzheimer’s
2. New Hope For Alzheimer’s Disease
3. Accidental Discovery Gives Hope to Alzheimer’s Treatment
4. Alzheimers Treatment: Hope Goes Ever On
5. Medication And Care Given To Alzheimer Patients